Company data
Janux Therapeutics, Inc. employees and revenue per employee
JANX · Biotechnology · $1.12B market cap
Janux Therapeutics, Inc. had 109 employees at the end of fiscal Dec 2025, up 34.6% from a year earlier. Revenue for the year was $10.0M, down 5.6% from a year earlier, or $92K per employee. Revenue fell while headcount grew.
Employees
109
+34.6% YoY
Revenue
$10.0M
-5.6% YoY
Revenue / employee
$92K
Peer median $459K
Rank in industry
92 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 109 | $10.0M | $92K | +34.6% | -5.6% |
| Dec 2024 | 81 | $10.6M | $131K | +26.6% | +31.0% |
| Dec 2023 | 64 | $8.1M | $126K | +6.7% | -6.1% |
| Dec 2022 | 60 | $8.6M | $144K | +81.8% | +136.8% |
| Dec 2021 | 33 | $3.6M | $110K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Janux Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CBIO Crescent Biopharma, Inc. | 44 | $10.8M | $246K | — |
| JANX Janux Therapeutics, Inc. | 109 | $10.0M | $92K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| ZBIO Zenas BioPharma, Inc. | 167 | $10.0M | $60K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
| AKTS Aktis Oncology, Inc. | 200,000 | $6.5M | $32 | — |
Questions about Janux Therapeutics, Inc.
- How many employees does Janux Therapeutics, Inc. have?
- Janux Therapeutics, Inc. reported 109 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 34.6% from a year earlier.
- What is Janux Therapeutics, Inc.'s revenue per employee?
- Janux Therapeutics, Inc. brought in $10.0M of revenue in fiscal Dec 2025, which is $92K per employee. That ranks 92 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare JANX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Janux Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell JANX.